Health system reconstitution syndrome: an often misunderstood phenomenon in global health practice.


Journal

Health policy and planning
ISSN: 1460-2237
Titre abrégé: Health Policy Plan
Pays: England
ID NLM: 8610614

Informations de publication

Date de publication:
01 Oct 2019
Historique:
accepted: 01 07 2019
pubmed: 10 8 2019
medline: 12 2 2020
entrez: 10 8 2019
Statut: ppublish

Résumé

The beginning of the 21st century was marked by the new definition and framework of health systems strengthening (HSS). The global movement to improve access to high-quality care garnered new resources to design and implement comprehensive HSS programs. In this effort, billions of dollars flowed from novel mechanisms such as The Global Fund to Fight AIDS, Tuberculosis and Malaria; Gavi, the Vaccine Alliance; and several bilateral funders. However, poor health outcomes, particularly in low-income countries, raise questions about the effectiveness of HSS program implementation. While several evaluation projects focus on the ultimate impact of HSS programs, little is known about the short- and mid-term reactions occurring throughout the active implementation of HSS interventions. Using the well-documented WHO framework of six HSS building blocks, we describe the evolution and phases of health system reconstitution syndrome (HSRS), including: (1) quiescent phase, (2) reactive phase, (3) restorative phase and (4) stability phase. We also discuss the implications of HSRS on global health funding, implementation, policy and research. Recognizing signs of HSRS could improve the rigour of HSS program design and minimize premature decisions regarding the progress of HSS interventions.

Identifiants

pubmed: 31397481
pii: 5545477
doi: 10.1093/heapol/czz072
doi:

Types de publication

Journal Article

Langues

eng

Pagination

618-624

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Anatole Manzi (A)

Clinical Department, Partners In Health, 800 Boylston Street Suite 300, Boston, MA, USA.
Department of Community Health, University of Rwanda College of Medicine and Health Sciences, KG 11 Ave, Kigali, Rwanda.

Alyssa Ierardo (A)

Department of Public Health and Community Medicine, Tufts University School of Medicine, 136 Harrison Avenue, Boston, MA, USA.

Jean Claude Mugunga (JC)

Clinical Department, Partners In Health, 800 Boylston Street Suite 300, Boston, MA, USA.

Cate Oswald (C)

Clinical Department, Partners In Health, 800 Boylston Street Suite 300, Boston, MA, USA.

Patrick Ulysse (P)

Clinical Department, Partners In Health, 800 Boylston Street Suite 300, Boston, MA, USA.

Eric Hansen (E)

Clinical Department, Partners In Health, 800 Boylston Street Suite 300, Boston, MA, USA.

Sheila Davis (S)

Clinical Department, Partners In Health, 800 Boylston Street Suite 300, Boston, MA, USA.

Joia Mukherjee (J)

Clinical Department, Partners In Health, 800 Boylston Street Suite 300, Boston, MA, USA.
Department of Global Health and Social Medicine, Harvard Medical School, 641 Huntington Avenue Boston, MA, USA.
Department of Medicine, Division of Global Health Equity, Brigham and Women's Hospital, 300 The Fenway, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH